{"SPADE_UN_16288": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_16288", "Peptide Name": "AmphiArc2 Off4", "Source": "Synthetic", "Family": "", "Gene": "Not found", "Sequence": "KYIRHLKTWFKKVFKLIGEV", "Sequence Length": 20, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Tumor cells:MCF-7 (EC50=11 ± 2 µM); A549 (EC50=15.0 ± 0.1 µM)", "Hemolytic Activity": "Human erythrocytes:HC50=20 ± 3 µM", "Cytotoxicity": "HDMEC:EC50=7.1 ± 0.1 µM", "Binding Target": "Not available", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Free", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C125H197N31O25", "Mass": 2534.09, "PI": 10.3, "Net Charge": 6, "Hydrophobicity": -0.17, "Half Life": "Mammalian:1.3 hourYeast:3 minE.coli:2 min", "Literature": [{"Title": "In silico design and optimization of selective membranolytic anticancer peptides", "Pubmed ID": "31375699", "Reference": "Sci Rep. 2019 Aug 2;9(1)11282.", "Author": "Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=31375699"}], "Frequent Amino Acids": "KFI", "Absent Amino Acids": "ACDMNOPQSU", "Basic Residues": 7, "Acidic Residues": 1, "Hydrophobic Residues": 10, "Polar Residues": 11, "Positive Residues": 7, "Negative Residues": 1, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_16298", "Similarity": 0.8, "Sequence": "HYIRHLKTWFHKPFKLIGKV"}, {"SPADE_ID": "SPADE_UN_16229", "Similarity": 0.625, "Sequence": "GLKKWFKKAVHVGKKVGKVALNAYL"}, {"SPADE_ID": "SPADE_N_13951", "Similarity": 0.6153846153846154, "Sequence": "SWFKKVFKPVEKVGQRVRDAGIQGVAIAQQGANVLATARGGPPH"}]}}}